News Posts List
T3 Labs sets gold standard in preclinical testing for CorAmi
08/17/2017
Dr. Rebecca Levit Dr. Levit is Assistant Professor of Cardiology at Emory University in Atlanta, GA and adjunct faculty in the Department of Biomedical Engineering at the Georgia Institute of Technology. She is also the Chief Scientific Officer of CorAmi Therapeutics. CorAmi is working in partnership with Emory University to develop a combination hydrogel delivery catheter and therapeutic hydrogel focused on cardiac applications, leading with a treatment for AF. Dr. Levit engaged regional medtech industry resources early in order to streamline the considerable developmental pathway for a Class III device: including GCMI and its subsidiary T3 Labs. Medtech innovation requires a healthy ecosystem Team testing the CorAmi device in the T3 Labs Cathlab (from L to R) : Dr. Gautam Kumar, Dr. Andres Garcia, Peter Campbell, Juline Deppen, Dr. Jose Garcia, Dr. Rebecca Levit What would you tell a physician innovator in your position when you started?
If you are a physician innovator, researcher, or medical device company of any size, and want to bring your new product to life as efficiently as possible, T3 Labs and GCMI can help from concept to cure through design & development, preclinical testing, bioskills training to commercialization. Contact us today. The photo of Dr. Rebecca Levit, as well as the CorAmi catheter, were taken by Emory Photo. |